Shandong Sito Bio-technology Co Ltd (300583) — Capital Reinvestment Ratio
Shandong Sito Bio-technology Co Ltd (300583) has a Capital Reinvestment Ratio of 0.71x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.13 Million) in capital expenditures (CN¥10.75 Million). Check 300583 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Sito Bio-technology Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Shandong Sito Bio-technology Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see 300583 operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Sito Bio-technology Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Sito Bio-technology Co Ltd from 2013 to 2025. See 300583 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.50x | CN¥158.53 Million | CN¥79.65 Million | ▲ +49.1% |
| 2024 | 0.34x | CN¥194.46 Million | CN¥65.53 Million | ▼ -65.9% |
| 2022 | 0.99x | CN¥145.34 Million | CN¥143.68 Million | ▼ -42.2% |
| 2021 | 1.71x | CN¥227.35 Million | CN¥388.92 Million | ▲ +79.5% |
| 2020 | 0.95x | CN¥254.60 Million | CN¥242.60 Million | ▼ -73.9% |
| 2019 | 3.66x | CN¥57.62 Million | CN¥210.73 Million | ▼ -47.1% |
| 2017 | 6.91x | CN¥10.90 Million | CN¥75.34 Million | ▲ +340.3% |
| 2016 | 1.57x | CN¥80.15 Million | CN¥125.87 Million | ▲ +4.7% |
| 2015 | 1.50x | CN¥87.10 Million | CN¥130.67 Million | ▲ +14.1% |
| 2014 | 1.31x | CN¥174.49 Million | CN¥229.42 Million | ▼ -29.5% |
| 2013 | 1.87x | CN¥24.95 Million | CN¥46.55 Million | — |